ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2

ClinicalTrials.gov ID: NCT01737762

Public ClinicalTrials.gov record NCT01737762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 11:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2

Study identification

NCT ID
NCT01737762
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Healthpoint
Industry
Enrollment
155 participants

Conditions and interventions

Interventions

  • HP802-247 Biological
  • Vehicle Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2012
Primary completion
Oct 31, 2015
Completion
Oct 31, 2015
Last update posted
Jul 25, 2017

2012 – 2015

United States locations

U.S. sites
37
U.S. states
19
U.S. cities
35
Facility City State ZIP Site status
Not listed Phoenix Arizona 85006
Not listed Phoenix Arizona 85012
Not listed Phoenix Arizona 85015
Not listed Carlsbad California 92009
Not listed Castro Valley California 94546
Not listed Fair Oaks California 95608
Not listed Fresno California 93720
Not listed Laguna Hills California 92653
Not listed Long Beach California 90822
Not listed Los Angeles California 90095
Not listed San Diego California 92013
Not listed Sylmar California 91342
Not listed Washington D.C. District of Columbia 20007
Not listed Hialeah Florida 33013
Not listed Miami Florida 33125
Not listed South Miami Florida 33143
Not listed Chicago Illinois 60611
Not listed Jacksonville Illinois 62650
Not listed Springfield Illinois 62702
Not listed Baltimore Maryland 21224
Not listed Boston Massachusetts 02118
Not listed Saginaw Michigan 48602
Not listed Washington Missouri 63090
Not listed Las Vegas Nevada 89119
Not listed Bayonne New Jersey 07002
Not listed Hoboken New Jersey 07030
Not listed East Meadow New York 11554
Not listed New York New York 10025
Not listed Chapel Hill North Carolina 27599
Not listed Akron Ohio 44307
Not listed Willoughby Ohio 44094
Not listed Tulsa Oklahoma 74127
Not listed Dunmore Pennsylvania 18512
Not listed Wyomissing Pennsylvania 19610
Not listed Knoxville Tennessee 37909
Not listed Fort Worth Texas 76107
Not listed Tacoma Washington 98431

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01737762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 25, 2017 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01737762 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →